Global office locator

Attending DIA in Philadelphia? Stop by Booth \#1426 to meet the ICON team and explore ICON’s solutions to improve speed, quality and efficiency across clinical development, from AI-enabled trial delivery to regulatory st...

ICON Biotech will be onsite at CTO East Coast, taking place 30 June – 1 July at the Boston Marriott Burlington, MA. As a leading provider of integrated clinical research services, ICON supports oncology and biotech compa...

Latest issue out now. Do you struggle to keep on top of regulatory changes affecting the world of medicine and medical device clinical trials? Join thousands of subscribers who have discovered the convenience of our fr...

Osivelotor is an oral investigational drug for the treatment of sickle cell disease (SCD) designed to inhibit hemoglobin polymerization. In a phase 1, open-label ADME study conducted in healthy participants at ICON’s cli...

Visit us at DIA Philadelphia, 14–18 June, Booth \#1426, and explore ICON’s solutions spanning AI-driven trials, regulatory strategy, faster start-up and high-performing site models. https://ow.ly/1VF950Z29B7

We’re pleased to be part of ACRO’s Good Clinical Podcast focused on advancing rare disease research through AI innovation and patient trust. In the discussion, ICON’s Tanya Binette highlights where AI is delivering valu...

More than a decade ago, Yordan Zahariev joined ICON as a Clinical Trial Assistant. Today, he leads one of ICON's largest CTA teams in Bulgaria as a Clinical Operations Manager. In our latest career story, Yordan reflect...

Attending CTO East Coast in Boston? Join Padma Varadharajan on 30 June at 9:30am for her core session entitled: “Practical considerations for navigating the landscape of global oncology trials in 2026 and beyond.” This ...

ICON is a proud supporter of Global Fatty Liver Awareness Day, raising awareness and driving change for the millions of people worldwide living with steatotic (fatty) liver disease, their families, and carers. By 2030, a...

Steatotic (fatty) liver disease is a silent global epidemic, often underdiagnosed despite its growing impact. Beyond the liver, it is closely linked to obesity, type 2 diabetes andhyperlipidaemia, driving significant car...

We're proud to share that ICON has been named one of Forbes America's Best Employers for New Graduates 2026. The recognition is based on independent surveys of early-career professionals across the US, covering culture,...

We are excited to announce that Cytek Aurora 5L Spectral Flow Cytometers are now live in our bioanalytical labs in the Netherlands and US. With the new addition we are offering: 1) Development/transfer, validation, and ...